Original Research

Published on 25 Mar 2021

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

in Cancer Immunity and Immunotherapy

Vinicius Araujo B. de Lima
Morten Hansen
Iben Spanggaard
Kristoffer Rohrberg
Sine Reker Hadrup
Ulrik Lassen
Inge Marie Svane

Frontiers in Oncology

doi 10.3389/fonc.2021.558248

7,253 views
23 citations

Systematic Review

Published on 23 Mar 2021

The Efficacy and Safety of Programmed Death-1 and Programmed Death Ligand 1 Inhibitors for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Shukang He
Weichao Jiang
Kai Fan
Xiaobei Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.626984

2,966 views
12 citations

Original Research

Published on 23 Mar 2021

Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer

in Cancer Immunity and Immunotherapy

Dongqiang Zeng
Miaohong Wang
Jiani Wu
Siheng Lin
Zilan Ye
Rui Zhou
Gaofeng Wang
Jianhua Wu
Huiying Sun
Jianping Bin

Frontiers in Oncology

doi 10.3389/fonc.2021.620688

7,633 views
11 citations

Original Research

Published on 22 Mar 2021

M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer

in Cancer Immunity and Immunotherapy

Yutao Wang
Kexin Yan
Jianfeng Wang
Jiaxing Lin
Jianbin Bi

Frontiers in Oncology

doi 10.3389/fonc.2021.609334

5,053 views
29 citations

Original Research

Published on 22 Mar 2021

Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Li Zhou
Litang Huang
Qiuli Xu
Yanling Lv
Zimu Wang
Ping Zhan
Hedong Han
Yang Shao
Dang Lin
Tangfeng Lv

Frontiers in Oncology

doi 10.3389/fonc.2021.596542

4,109 views
7 citations

Systematic Review

Published on 19 Mar 2021

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis

in Cancer Immunity and Immunotherapy

Run-Cong Nie
Guo-Ming Chen
Yun Wang
Jie Zhou
Jin-Ling Duan
Zhi-Wei Zhou
Shu-Qiang Yuan

Frontiers in Oncology

doi 10.3389/fonc.2021.538174

4,291 views
16 citations

Original Research

Published on 19 Mar 2021

CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer

in Cancer Immunity and Immunotherapy

Keiichiro Kumamoto
Takashi Tasaki
Koji Ohnishi
Michihiko Shibata
Shohei Shimajiri
Masaru Harada
Yoshihiro Komohara
Toshiyuki Nakayama

Frontiers in Oncology

doi 10.3389/fonc.2021.636751

3,599 views
14 citations

Review

Published on 18 Mar 2021

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Wanting Hou
Xiaohan Zhou
Cheng Yi
Hong Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.604227

4,604 views
13 citations

Original Research

Published on 18 Mar 2021

Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer

in Cancer Immunity and Immunotherapy

Hyunjong Lee
Kwon Joong Na
Hongyoon Choi

Frontiers in Oncology

doi 10.3389/fonc.2021.649004

6,249 views
30 citations

Original Research

Published on 18 Mar 2021

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression

in Cancer Immunity and Immunotherapy

Jiayun Yu
Hanwen Li
Zongliang Zhang
Weimin Lin
Xiawei Wei
Bin Shao

Frontiers in Oncology

doi 10.3389/fonc.2021.647312

3,406 views
15 citations

Original Research

Published on 18 Mar 2021

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Xue Wang
Xiaomin Niu
Na An
Yile Sun
Zhiwei Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.611012

5,818 views
27 citations

Systematic Review

Published on 18 Mar 2021

Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review

in Cancer Immunity and Immunotherapy

Chengliang Huang
Meizhang Li
Ben Liu
Huanbo Zhu
Qun Dai
Xianming Fan
Kathan Mehta
Chao Huang
Prakash Neupane
Fen Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.642110

7,781 views
39 citations

Review

Published on 16 Mar 2021

Modeling Radioimmune Response—Current Status and Perspectives

in Cancer Immunity and Immunotherapy

Thomas Friedrich
Nicholas Henthorn
Marco Durante

Frontiers in Oncology

doi 10.3389/fonc.2021.647272

3,003 views
12 citations

Original Research

Published on 16 Mar 2021

Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining

in Cancer Immunity and Immunotherapy

Haiyan Zhang
Yongfei Xie
Zhi Hu
Hong Yu
Xiang Xie
Yingchun Ye
Wenfeng Xu
Siji Nian
Qing Yuan

Frontiers in Oncology

doi 10.3389/fonc.2021.608113

5,804 views
11 citations

Review

Published on 15 Mar 2021

Small Extracellular Vesicles: A Novel Avenue for Cancer Management

in Cancer Immunity and Immunotherapy

Yanan Gao
You Qin
Chao Wan
Yajie Sun
Jingshu Meng
Jing Huang
Yan Hu
Honglin Jin
Kunyu Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.638357

16,978 views
53 citations

Review

Published on 11 Mar 2021

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade

in Cancer Immunity and Immunotherapy

Yanna Lei
Xiaoying Li
Qian Huang
Xiufeng Zheng
Ming Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.617335

12,041 views
67 citations

Navigation group

Articles

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

The Efficacy and Safety of Programmed Death-1 and Programmed Death Ligand 1 Inhibitors for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer

M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer

Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis

CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer

Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer

Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review

Modeling Radioimmune Response—Current Status and Perspectives

Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining

Small Extracellular Vesicles: A Novel Avenue for Cancer Management

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade